Fig. 5: Disulfidptosis subtypes in pan-cancer.
From: Pan-cancer analysis uncovered the prognostic and therapeutic value of disulfidptosis
A The tumor-associated pathways GSVA score of DRGs in pan-cancer. B Prognostic value of DRGs for pan-cancer patients. C Cluster analysis, D DRGs expression heatmap, E GSVA scores of cell cycle and EMT pathways, F Estimate score, G immune cell infiltration, and H DSS, DFI, OS, and PFI differences between two disulfidptosis subtypes. DSS disease-specific survival, DFI disease-free interval, OS overall survival, PFI progression-free interval.
